Literature DB >> 9122358

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence.

A C King1, J R Volpicelli, A Frazer, C P O'Brien.   

Abstract

We investigated specific subjective effects of naltrexone pretreatment or placebo during various intervals on the breath alcohol level (BAL) curve in nonalcoholic volunteers. Fifteen high-risk (social drinkers with an alcoholic father) and 14 low-risk (no alcoholic relatives in at least two generations) subjects were tested in a double-blind placebo-controlled study of the effects of 50 mg oral naltrexone on response to a moderate dose of alcohol. Dependent measures included subjective stimulation and sedation subscales from the Biphasic Alcohol Effects Scale (BAES) and mood subscales from the Profile of Mood States (POMS). At rising BALs, high-risk subjects showed a naltrexone-related attenuation of BAES stimulation. This effect was not evident in low-risk subjects, who directionally showed the opposite effect, although nonsignificant. For both groups, there were no significant naltrexone-related effects for BAES sedation; however, naltrexone did affect several POMS scales on alcohol response, such as decreased vigor, and increased fatigue, tension, and confusion. Confusion was significantly elevated for the high-risk group during rising BALs of the naltrexone session. The results suggest a differential response to naltrexone, based on paternal history of alcoholism and level of stimulation experienced during alcohol drinking.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122358     DOI: 10.1007/s002130050156

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  76 in total

Review 1.  Functional genomics strategies to identify susceptibility genes and treatment targets in alcohol dependence.

Authors:  Markus Heilig; Wolfgang Sommer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 2.  Human laboratory paradigms in alcohol research.

Authors:  Jennifer G Plebani; Lara A Ray; Meghan E Morean; William R Corbin; James MacKillop; Michael Amlung; Andrea C King
Journal:  Alcohol Clin Exp Res       Date:  2012-02-06       Impact factor: 3.455

Review 3.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

Review 4.  Extended-release intramuscular naltrexone.

Authors:  Tracy Swainston Harrison; Greg L Plosker; Susan J Keam
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Acute effects of low and high dose alcohol on smoking lapse behavior in a laboratory analogue task.

Authors:  Christopher W Kahler; Jane Metrik; Nichea S Spillane; Anne Day; Adam M Leventhal; Sherry A McKee; Jennifer W Tidey; John E McGeary; Valerie S Knopik; Damaris J Rohsenow
Journal:  Psychopharmacology (Berl)       Date:  2014-05-25       Impact factor: 4.530

6.  Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool.

Authors:  Erica N Grodin; Spencer Bujarski; Alexandra Venegas; Wave-Ananda Baskerville; Steven J Nieto; J David Jentsch; Lara A Ray
Journal:  Alcohol Alcohol       Date:  2019-12-01       Impact factor: 2.826

Review 7.  Pharmacogenetic approaches to the treatment of alcohol addiction.

Authors:  Markus Heilig; David Goldman; Wade Berrettini; Charles P O'Brien
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

8.  Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats.

Authors:  Angela Henderson-Redmond; Cristine Czachowski
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

Review 9.  Relapse prevention and maintaining abstinence in older adults with alcohol-use disorders.

Authors:  Christopher Barrick; Gerard J Connors
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  Effects of naltrexone on cortisol levels in heavy drinkers.

Authors:  Lara A Ray; James Mackillop; Lorenzo Leggio; Marilee Morgan; Kent E Hutchison
Journal:  Pharmacol Biochem Behav       Date:  2008-09-13       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.